abatacept
Selected indexed studies
- Trial of Upadacitinib or Abatacept in Rheumatoid Arthritis. (N Engl J Med, 2020) [PMID:33053283]
- Abatacept. (BioDrugs, 2006) [PMID:16573350]
- Abatacept for the treatment of rheumatoid arthritis. (Expert Rev Clin Immunol, 2019) [PMID:30730220]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Trial of Upadacitinib or Abatacept in Rheumatoid Arthritis. (2020) pubmed
- Abatacept. (2006) pubmed
- Abatacept for the treatment of rheumatoid arthritis. (2019) pubmed
- Abatacept and the risk of malignancy: a meta-analysis across disease indications. (2025) pubmed
- [Abatacept]. (2016) pubmed
- Abatacept in individuals at high risk of rheumatoid arthritis (APIPPRA): a randomised, double-blind, multicentre, parallel, placebo-controlled, phase 2b clinical trial. (2024) pubmed
- Abatacept: A Review in Rheumatoid Arthritis. (2017) pubmed
- Abatacept dose-finding phase II triaL for immune checkpoint inhibitors myocarditis (ACHLYS) trial design. (2025) pubmed
- Efficacy and safety of abatacept for systemic juvenile idiopathic arthritis: A systematic review. (2024) pubmed
- Efficacy and Safety of Subcutaneous Abatacept Plus Standard Treatment for Active Idiopathic Inflammatory Myopathy: Phase 3 Randomized Controlled Trial. (2025) pubmed